| mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.001 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.003 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
| mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.004 |
| mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |